Oculis completes patient recruitment for stage 1 of Phase 3 DIAMOND study evaluating the efficacy and safety of OCS-01 in diabetic macular edema (DME)
January 05, 2023 06:00 ET
|
Oculis
Oculis completes patient recruitment for stage 1 of Phase 3 DIAMOND study evaluating the efficacy and safety of OCS-01 in diabetic macular edema (DME) Oculis has completed enrollment for stage 1...
Retina-Vitreous Associates Medical Group Offers Patients First FDA Approved Non-Surgical Therapy for Sight Threatening Condition
February 05, 2013 08:30 ET
|
Retina-Vitreous Associates Medical Group
BEVERLY HILLS, Calif., Feb. 5, 2013 (GLOBE NEWSWIRE) -- Retina-Vitreous Associates Medical Group, nationally recognized leaders that specialize in the treatment of diseases affecting the retina, are...